Safety and Tolerability of Ranibizumab in Mono/Bilateral Wet Age Related Macular Degeneration (w-AMD) Patients in Eyes With BCVA<2/10 and/or 2nd Affected Eye

Clinical trial NCT01986907 · COMPLETED

Trial details

NCT number

NCT01986907

Sponsor

Novartis Pharmaceuticals

Status

COMPLETED

Phase

Phase 4

Study type

INTERVENTIONAL

Start date

2014-03-04

Primary completion

2016-06-15

Enrollment

1049

View on ClinicalTrials.gov